Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00222859 · ClinicalTrials.gov registry record
Reasons for Non-treatment of Hepatitis C in HCV Mono-infected Patients Versus HCV-HIV Co-infected Patients in a University Setting
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 300
- Enrollment target
NCT00222859 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 300 participants.
The verdict
NCT00222859 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
The specific aims of this study are to determine the treatment prescription rates for Hepatitis C virus (HCV) infection in a cohort of HCV mono-infected, and human immunodeficiency virus (HIV)-HCV co-infected patients and to identify the reasons for non-treatment of HCV in these two groups.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2005-03 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00222859
The ClinicalTrials.gov registry entry for NCT00222859 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00222859 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00222859 about?
NCT00222859 is a clinical study titled "Reasons for Non-treatment of Hepatitis C in HCV Mono-infected Patients Versus HCV-HIV Co-infected Patients in a University Setting". The specific aims of this study are to determine the treatment prescription rates for Hepatitis C virus (HCV) infection in a cohort of HCV mono-infected, and human immunodeficiency virus (HIV)-HCV co-infected patients and to identify the reasons for non-treatment of HCV in these two groups.
What is the current status of trial NCT00222859?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2005-03. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT00222859?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.